104 related articles for article (PubMed ID: 30396939)
1. Suppression of Taxanes Cytotoxicity by Citrus Flavonoid Hesperetin in PPC-1 Human Prostate Cancer Cells.
Sak K; Lust H; Kase M; Saar M; Jaal J
Anticancer Res; 2018 Nov; 38(11):6209-6215. PubMed ID: 30396939
[TBL] [Abstract][Full Text] [Related]
2. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H
Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines.
Sak K; Kasemaa K; Everaus H
Food Funct; 2016 Sep; 7(9):3815-24. PubMed ID: 27489195
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
[TBL] [Abstract][Full Text] [Related]
5. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks.
Adan A; Baran Y
Tumour Biol; 2015 Nov; 36(11):8973-84. PubMed ID: 26081618
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory potential of hesperetin and chrysin through the cellular and humoral response.
Sassi A; Mokdad Bzéouich I; Mustapha N; Maatouk M; Ghedira K; Chekir-Ghedira L
Eur J Pharmacol; 2017 Oct; 812():91-96. PubMed ID: 28690190
[TBL] [Abstract][Full Text] [Related]
7. Preclinical profile of cabazitaxel.
Vrignaud P; Semiond D; Benning V; Beys E; Bouchard H; Gupta S
Drug Des Devel Ther; 2014; 8():1851-67. PubMed ID: 25378905
[TBL] [Abstract][Full Text] [Related]
8. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
Vrignaud P; Sémiond D; Lejeune P; Bouchard H; Calvet L; Combeau C; Riou JF; Commerçon A; Lavelle F; Bissery MC
Clin Cancer Res; 2013 Jun; 19(11):2973-83. PubMed ID: 23589177
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
Martin SK; Kyprianou N
Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
[TBL] [Abstract][Full Text] [Related]
10. Role of taxanes in advanced prostate cancer.
Cassinello J; Carballido Rodríguez J; Antón Aparicio L
Clin Transl Oncol; 2016 Oct; 18(10):972-80. PubMed ID: 26856599
[TBL] [Abstract][Full Text] [Related]
11. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer.
Ramachandran K; Speer C; Nathanson L; Claros M; Singal R
Anticancer Res; 2016 Jan; 36(1):161-8. PubMed ID: 26722040
[TBL] [Abstract][Full Text] [Related]
13. Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis.
Ghoochani A; Hatipoglu Majernik G; Sehm T; Wach S; Buchfelder M; Taubert H; Eyupoglu IY; Savaskan N
Oncotarget; 2016 Jun; 7(25):38306-38318. PubMed ID: 27203678
[TBL] [Abstract][Full Text] [Related]
14. The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways.
Alshatwi AA; Ramesh E; Periasamy VS; Subash-Babu P
Fundam Clin Pharmacol; 2013 Dec; 27(6):581-92. PubMed ID: 22913657
[TBL] [Abstract][Full Text] [Related]
15. Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial-Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1
Qian J; Shen S; Chen W; Chen N
Biomed Res Int; 2018; 2018():4174232. PubMed ID: 29568752
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7 - a comparative study.
Kabała-Dzik A; Rzepecka-Stojko A; Kubina R; Iriti M; Wojtyczka RD; Buszman E; Stojko J
Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(8):1-10. PubMed ID: 29981677
[TBL] [Abstract][Full Text] [Related]
17. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
[TBL] [Abstract][Full Text] [Related]
18. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
[TBL] [Abstract][Full Text] [Related]
19. The impact of taxanes on the management of genitourinary cancers.
Balar AV
Anticancer Drugs; 2014 May; 25(5):555-60. PubMed ID: 24525590
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
